Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Employees

4,619

Sector

Pharmaceuticals

Calendar

2025-03-30 - Q4 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
24-12-10	31.98 ¥	+1.11%	5,172,996
24-12-09	31.63 ¥	-1.25%	3,465,987
24-12-06	32.03 ¥	+0.91%	3,842,706
24-12-05	31.74 ¥	-0.06%	3,146,000
24-12-04	31.76 ¥	-1.58%	4,075,604

End-of-day quote Shanghai S.E., December 09, 2024

More quotes

Income Statement and Estimates

income-statement-evolution-chart TIANJIN-PHARMACEUTICAL-DA

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

C

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

2

Last Close Price

31.98

Average target price

-

Consensus

Profit revisions

estimates-change-chart TIANJIN-PHARMACEUTICAL-DA

Estimate revisions

Annual profits - Rate of surprise

quality-estimates-chart TIANJIN-PHARMACEUTICAL-DA

Company calendar

End-of-day quote Shanghai S.E. Other stock markets 2024-12-10			5-day change	1st Jan Change
31.98 ^CNY	+1.11%		-0.90%	-4.96%

Dec. 10	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Resignation of Wang Lei as General Manager	CI
Nov. 27	Tianjin Pharmaceutical Da Ren Tang Group Appoints Chair	MT

Capitalization	21.31B 2.94B 2.8B 2.59B 2.3B 4.16B 249B 4.61B 32.27B 11.91B 102B 11.03B 10.79B 447B	P/E ratio 2024 *	21.7x	P/E ratio 2025 *	18.4x
Enterprise value	21.31B 2.94B 2.8B 2.59B 2.3B 4.16B 249B 4.61B 32.27B 11.91B 102B 11.03B 10.79B 447B	EV / Sales 2024 *	2.44x	EV / Sales 2025 *	2.23x
Free-Float	31.72%	Yield 2024 *	-	Yield 2025 *	-

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Resignation of Wang Lei as General Manager	Dec. 10	CI
Tianjin Pharmaceutical Da Ren Tang Group Appoints Chair	Nov. 27	MT
Tianjin Pharmaceutical Appoints Chairman	Nov. 26	MT
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Approves Election of Wang Lei as Chairman of the Board	Nov. 26	CI
Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Up 8% in Q3	Oct. 30	MT
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2024	Oct. 30	CI
Global markets live: Stellantis, Apple, Spotify, Verizon, At&T...	Sep. 30
Singapore Shares Close Higher Despite Weak Import/Export Data; Tianjin Pharmaceutical Surges 7%	Sep. 30	MT
Tianjin Pharmaceutical Da Ren Tang Approves Sale of 13% Stake in Tianjin TSKF Pharma; Shares Surge 10%	Sep. 30	MT
Haleon Raising Stake in Tianjin TSKF Pharmaceutical JV to 88%	Sep. 29	MT
Haleon Increases Stake in China JV to 88% for GBP500 Million	Sep. 27	DJ
Haleon plc entered into agreement to acquire 33% stake in Tianjin TSKF Pharmaceutical Co. Ltd from Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited and Tianjin Pharmaceutical Group Co., Ltd. for CNY 4.5 billion.	Sep. 26	CI
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(SGX:T14) added to S&P Global BMI Index	Sep. 22	CI

Nouveau feu d'artifice boursier en Chine	Sep. 30
En direct des marchés : Stellantis avertit, Volkswagen avertit, Aston Martin avertit	Sep. 30
Borsa di Italia: nuovi fuochi d'artificio sul mercato azionario cinese	Sep. 30
Bolsa de Madrid: Nuevos fuegos artificiales bursátiles en China	Sep. 30

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock

Equities

600329

CNE000001808

Pharmaceuticals

Valuation: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Chart: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Latest news: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Press Releases: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

News in other languages: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Quotes and Performance

Course Extremes

Managers and Directors: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Alternative Medicine

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Annual profits - Rate of surprise

1 day	+1.11%
1 week	-1.60%
Current month	-0.87%
1 month	-8.76%
3 months	+16.55%
6 months	-13.10%
Current year	-4.96%

Director	Title	Age	Since
Lei Wang CEO	Chief Executive Officer	53	2022-08-21
Jian Ma DFI	Director of Finance/CFO	46	2023-07-20
Hong Zhou CTO	Chief Tech/Sci/R&D Officer	54	2017-10-09

Manager	Title	Age	Since
Lei Wang CHM	Chairman	53	2024-11-25
Hong Zhou BRD	Director/Board Member	54	2012-11-30
Yoke Pheng Liew BRD	Director/Board Member	68	2020-06-04

	2024 *	2025 *
Net sales	8.72B 1.2B 1.14B 1.06B 944M 1.7B 102B 1.89B 13.21B 4.88B 41.92B 4.52B 4.42B 183B	9.54B 1.32B 1.25B 1.16B 1.03B 1.86B 112B 2.07B 14.45B 5.34B 45.85B 4.94B 4.83B 200B
Net income	1.14B 157M 149M 138M 123M 222M 13.31B 246M 1.72B 636M 5.47B 589M 576M 23.85B	1.34B 184M 175M 163M 145M 261M 15.64B 289M 2.02B 747M 6.42B 692M 677M 28.03B
Net Debt	-	-

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+1.11%	-1.60%	-7.63%	+21.32%	2.91B
DONG-E-E-JIAO CO.,LTD.	+1.18%	-0.21%	+15.80%	+30.53%	5.08B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-0.18%	-2.76%	-32.12%	+1.44%	3.9B
TASLY PHARMACEUTICAL GROUP CO., LTD	+0.42%	-1.56%	-7.94%	+4.02%	2.97B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.29%	+0.18%	-3.13%	-9.17%	2.49B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-0.71%	-0.48%	-4.58%	-3.70%	1.74B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+0.32%	-2.08%	+30.33%	+61.34%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	-2.57%	-4.15%	-17.44%	1.63B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	-1.15%	-5.06%	+65.58%	+100.86%	1.56B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	+0.35%	+1.07%	-31.57%	-44.08%	1.33B
Average	+0.17%	-0.81%	+2.06%	+14.51%	2.53B
Weighted average by Cap.	+0.34%	-0.54%	-0.08%	+14.97%